Beta Bionics, Inc. Common Stock BBNX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $30.21M-4.3% | $31.58M-18.0% | $38.49M+9.7% | $35.08M-17.4% | $42.45M+39.5% | ||
| $169.31M-9.7% | $187.55M-1.4% | $190.2M-11.4% | $214.65M+13.6% | $189.02M+158% | ||
| $100K0.0% | $100K0.0% | $100K0.0% | $100K0.0% | $100K0.0% | ||
| $15.75M-8.0% | $17.12M+48.3% | $11.54M+1.3% | $11.4M+25.8% | $9.06M-24.5% | ||
| $23.73M+9.2% | $21.72M+6.6% | $20.37M+17.6% | $17.32M+10.1% | $15.73M+18.1% | ||
| $8.89M-9.7% | $9.84M+4.4% | $9.43M+23.4% | $7.64M+35.1% | $5.65M+40.2% | ||
| $247.99M-7.4% | $267.91M-0.8% | $270.03M-5.6% | $286.08M+9.2% | $261.92M+97.0% | ||
| $10.16M+18.1% | $8.6M+16.5% | $7.39M+14.2% | $6.47M+17.2% | $5.52M+15.5% | ||
| $6.23M-6.1% | $6.63M-5.7% | $7.02M+16.3% | $6.04M-4.8% | $6.34M-4.5% | ||
| $181K+0.6% | $180K-1.6% | $183K+27.1% | $144K-1.4% | $146K-2.7% | ||
| $39.87M-12.3% | $45.43M+0.2% | $45.33M+45.5% | $31.15M-51.3% | $64M— | ||
| $304.42M-7.4% | $328.74M-0.4% | $330.05M0.0% | $329.97M-2.4% | $338.02M+126% | ||
| $2.32M-53.6% | $5M+12.0% | $4.46M+30.3% | $3.42M-0.9% | $3.45M+21.1% | ||
| $17.33M-22.7% | $22.43M+27.4% | $17.61M+31.3% | $13.41M+26.9% | $10.57M-33.3% | ||
| $3.35M+1.6% | $3.3M+10.4% | $2.99M+11.8% | $2.67M+14.6% | $2.33M+25.3% | ||
| $1.84M-5.1% | $1.94M-2.1% | $1.98M+30.3% | $1.52M-0.3% | $1.52M-0.3% | ||
| $23.19M-25.0% | $30.92M+21.8% | $25.39M+30.3% | $19.49M+18.2% | $16.49M-22.0% | ||
| $5.07M-5.4% | $5.37M-6.0% | $5.71M+10.4% | $5.17M-5.2% | $5.45M-4.8% | ||
| $6.91M-5.4% | $7.3M-5.0% | $7.69M+15.0% | $6.69M-4.1% | $6.97M-3.9% | ||
| $1.56M+0.7% | $1.55M+28.4% | $1.21M+19.2% | $1.01M— | —— | ||
| $33.17M-19.4% | $41.13M+16.6% | $35.29M+24.5% | $28.34M+16.8% | $24.27M-67.0% | ||
| $5K+25.0% | $4K0.0% | $4K0.0% | $4K0.0% | $4K+300% | ||
| $663.17M+0.9% | $657.14M+1.0% | $650.87M+1.1% | $643.74M+0.8% | $638.9M+1,145% | ||
| -$391.83M-5.9% | -$369.94M-3.8% | -$356.47M-4.2% | -$342.26M-5.2% | -$325.39M-9.7% | ||
| -$96K-124% | $403K+13.8% | $354K+138% | $149K-37.9% | $240K+269% | ||
| $271.25M-5.7% | $287.61M-2.4% | $294.76M-2.3% | $301.63M-3.9% | $313.75M+228% | ||
| $304.42M-7.4% | $328.74M-0.4% | $330.05M0.0% | $329.97M-2.4% | $338.02M+126% | ||
| $181K+0.6% | $180K-1.6% | $183K+27.1% | $144K-1.4% | $146K-2.7% | ||
| $6.23M-6.1% | $6.63M-5.7% | $7.02M+16.3% | $6.04M-4.8% | $6.34M-4.5% | ||
| $39.87M-12.3% | $45.43M+0.2% | $45.33M+45.5% | $31.15M-51.3% | $64M— | ||
| $6.23M-6.1% | $6.63M-5.7% | $7.02M+16.3% | $6.04M-4.8% | $6.34M-4.5% | ||
| $181K+0.6% | $180K-1.6% | $183K+27.1% | $144K-1.4% | $146K-2.7% | ||
| $169.31M-9.7% | $187.55M-1.4% | $190.2M-11.4% | $214.65M+13.6% | $189.02M+158% | ||
| $6.23M-6.1% | $6.63M-5.7% | $7.02M+16.3% | $6.04M-4.8% | $6.34M-4.5% | ||
| $181K+0.6% | $180K-1.6% | $183K+27.1% | $144K-1.4% | $146K-2.7% | ||
| $1.71M+9.5% | $1.56M+16.0% | $1.34M+17.6% | $1.14M+20.2% | $949K+1.1% | ||
| $17.33M-22.7% | $22.43M+27.4% | $17.61M+31.3% | $13.41M+26.9% | $10.57M-33.3% | ||
| $3.35M+1.6% | $3.3M+10.4% | $2.99M+11.8% | $2.67M+14.6% | $2.33M+25.3% | ||
| $6.91M-5.4% | $7.3M-5.0% | $7.69M+15.0% | $6.69M-4.1% | $6.97M-3.9% | ||
| $5K+25.0% | $4K0.0% | $4K0.0% | $4K0.0% | $4K+300% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Beta Bionics, Inc. Common Stock's total assets?
- Beta Bionics, Inc. Common Stock (BBNX) holds $304.4M in total assets, down 9.9% year over year.
- How much debt does Beta Bionics, Inc. Common Stock have?
- Beta Bionics, Inc. Common Stock carries $6.9M in total debt against $271.2M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Beta Bionics, Inc. Common Stock have?
- Beta Bionics, Inc. Common Stock holds $30.2M in cash and equivalents.
- Can Beta Bionics, Inc. Common Stock cover its short-term obligations?
- Its current ratio is 10.69 — current assets exceed current liabilities.
- Where does Beta Bionics, Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Beta Bionics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
